Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
Celgene Corporation, a wholly owned subsidiary of Bristol-Myers Squibb Company, is a global biopharmaceutical company committed to improving the lives of patients worldwide through innovative therapies in oncology, immunology, and inflammation. The website serves as a comprehensive resource for healthcare professionals, patients, and investors, providing detailed information about the company's products, research, and development efforts.
0 / day
0 / day
0 pages per visit
Domain Rating
Domain Authority
Citation Level
English, etc
Detailed descriptions and prescribing information for Celgene's portfolio of innovative therapies.
Insights into Celgene's commitment to advancing science and developing new treatments for patients.
Financial reports, stock information, and updates on corporate developments for investors.
Resources and support programs for patients prescribed Celgene therapies.
Educational materials, clinical trial information, and professional resources for healthcare providers.
Press releases, media contacts, and the latest news from Celgene.
Information on Celgene's efforts in sustainability, ethics, and community engagement.
Job openings and information about working at Celgene.
Summit, New Jersey, United States
Bristol-Myers Squibb Company
Mark J. Alles (Former CEO), Giovanni Caforio (Chairman and CEO of Bristol-Myers Squibb)
Approximately 9,000 (as of the last available data)
$17.0 billion (2019)
https://www.celgene.com
Security headers report is a very important part of user data protection. Learn more about http headers for celgene.com